IL6 and myeloproliferative disorder: Therefore, MPN and particularly PMF patients are characterized by elevated levels of inflammatory cytokines, including interleukin (IL)−1ß, IL-6, tumor necrosis factor alpha (TNF-α), and interferon alpha (IFN-α)10–16.